Search This Blog

Wednesday, November 8, 2023

Akebia Results and Recent Business Highlights

 


Akebia to host conference call at 8:00 a.m. ET

  • Vadadustat NDA assigned a PDUFA date of March 27, 2024
  • Vadadustat approved in 36 countries, including Australia and Taiwan
  • Akebia strengthens cash position modifying Pharmakon loan
  • Auryxia® (ferric citrate) quarterly net product revenue of $40.1 million

Akebia will host a conference call and webcast on Wednesday, November 8 at 8:00 a.m. ET to discuss its financial results and recent business highlights. To access the call, please register by clicking on this Registration Link, and you will be provided with dial in details. To avoid delays and ensure timely connection, we encourage dialing into the conference call 15 minutes ahead of the scheduled start time.

A live webcast of the conference call will be available via the "Investors" section of Akebia's website at: https://ir.akebia.com/. An online archive of the webcast can be accessed via the Investors section of Akebia's website at https://ir.akebia.com approximately two hours after the event.


No comments:

Post a Comment

Note: Only a member of this blog may post a comment.